Matches in SemOpenAlex for { <https://semopenalex.org/work/W2557139681> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- W2557139681 abstract "Background Hepatitis B vaccination is recommended for rheumatoid arthritis (RA) patients in many international guideline. However, the short-term and long-term efficacies of hepatitis B vaccination in RA patients that recieved conventional and/or biological disease-modifying anti-rheumatic drugs (cDMARDs and/or bDMARDs) are not clearly established. Objectives To assess the long term of immunogenicity of the hepatitis B vaccination in rheumatoid arthritis (RA) patients receiving cDMARDs and/or bDMARDs. Methods The study comprised 45 patients with RA, of whom 33 received cDMARDs and 12 received bDMARDs therapy (study group), and 9 subjects with age- and sex-matched healthy controls (control group). All subjects were vaccinated with 20 μg of recombinant hepatitis B vaccine (Euvax B®) at weeks 0, 4, and 24. Blood samples were collected 8 weeks and 12 months after receipt of the third vaccine dose to test for antibody to hepatitis B surface antigen (anti-HBs). Responders (seroprotection) were defined as anti-HBs level ≥10 mIU/mL. The study was approved by the ethic committee and institutional review board. Results Baseline characteristics of study and control groups were similar. Patients receiving cDMARDs tended to has lower proportion of seroprotection than control group (69.7% vs 100%, p=0.09) at 2 months and (57.57% vs 100%, p=0.016) 12 months after receipt of the third vaccine dose. Patients receiving bDMARDs had a significantly lower proportion of seroprotection compared with control group (50% vs 100%, p=0.02) at both 8 weeks and 12 months after receipt of the third vaccine dose. The proportion of seroprotection is significantly decreased between 2 months and 12 months in patients receiving cDMARDs (69.7% vs 57.57%, p=0.044) after completion of the third dose vaccine. Conclusions DMARDs both conventional and biological DMARDs therapy impaired short-term and long-term immunogenic response to hepatitis B vaccine. Disclosure of Interest None declared" @default.
- W2557139681 created "2016-11-30" @default.
- W2557139681 creator A5000322305 @default.
- W2557139681 creator A5014870649 @default.
- W2557139681 creator A5023214548 @default.
- W2557139681 creator A5035075515 @default.
- W2557139681 creator A5041962501 @default.
- W2557139681 creator A5073602823 @default.
- W2557139681 date "2016-06-01" @default.
- W2557139681 modified "2023-09-27" @default.
- W2557139681 title "SAT0086 The Short-Term and Long-Term of Humeral Immune Responses To Hepatitis B Vaccination Are Impaired in Rheumatoid Arthritis Patients Receiving Conventional and Biological Disease Modifying Anti-Rheumatic Drugs" @default.
- W2557139681 doi "https://doi.org/10.1136/annrheumdis-2016-eular.5505" @default.
- W2557139681 hasPublicationYear "2016" @default.
- W2557139681 type Work @default.
- W2557139681 sameAs 2557139681 @default.
- W2557139681 citedByCount "0" @default.
- W2557139681 crossrefType "journal-article" @default.
- W2557139681 hasAuthorship W2557139681A5000322305 @default.
- W2557139681 hasAuthorship W2557139681A5014870649 @default.
- W2557139681 hasAuthorship W2557139681A5023214548 @default.
- W2557139681 hasAuthorship W2557139681A5035075515 @default.
- W2557139681 hasAuthorship W2557139681A5041962501 @default.
- W2557139681 hasAuthorship W2557139681A5073602823 @default.
- W2557139681 hasConcept C126322002 @default.
- W2557139681 hasConcept C203014093 @default.
- W2557139681 hasConcept C22070199 @default.
- W2557139681 hasConcept C2522874641 @default.
- W2557139681 hasConcept C2777226972 @default.
- W2557139681 hasConcept C2777382497 @default.
- W2557139681 hasConcept C2777410769 @default.
- W2557139681 hasConcept C2777575956 @default.
- W2557139681 hasConcept C2780593183 @default.
- W2557139681 hasConcept C2781037505 @default.
- W2557139681 hasConcept C2781290027 @default.
- W2557139681 hasConcept C71924100 @default.
- W2557139681 hasConceptScore W2557139681C126322002 @default.
- W2557139681 hasConceptScore W2557139681C203014093 @default.
- W2557139681 hasConceptScore W2557139681C22070199 @default.
- W2557139681 hasConceptScore W2557139681C2522874641 @default.
- W2557139681 hasConceptScore W2557139681C2777226972 @default.
- W2557139681 hasConceptScore W2557139681C2777382497 @default.
- W2557139681 hasConceptScore W2557139681C2777410769 @default.
- W2557139681 hasConceptScore W2557139681C2777575956 @default.
- W2557139681 hasConceptScore W2557139681C2780593183 @default.
- W2557139681 hasConceptScore W2557139681C2781037505 @default.
- W2557139681 hasConceptScore W2557139681C2781290027 @default.
- W2557139681 hasConceptScore W2557139681C71924100 @default.
- W2557139681 hasLocation W25571396811 @default.
- W2557139681 hasOpenAccess W2557139681 @default.
- W2557139681 hasPrimaryLocation W25571396811 @default.
- W2557139681 isParatext "false" @default.
- W2557139681 isRetracted "false" @default.
- W2557139681 magId "2557139681" @default.
- W2557139681 workType "article" @default.